Evidence map›Paper›PMID 38424172›Full record

ArticleScientific reports2024

Elucidating hepatocellular carcinoma progression: a novel prognostic miRNA-mRNA network and signature analysis.

Fei Wang, Xichun Kang, Yaoqi Li, Jianhua Lu, Xiling Liu, Huimin Yan

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Fei WangClinical Research Center, Shijiazhuang Fifth Hospital, Shijiazhuang, Hebei, China.
Xichun KangClinical Research Center, Shijiazhuang Fifth Hospital, Shijiazhuang, Hebei, China.
Yaoqi LiClinical Research Center, Shijiazhuang Fifth Hospital, Shijiazhuang, Hebei, China.
Jianhua LuClinical Research Center, Shijiazhuang Fifth Hospital, Shijiazhuang, Hebei, China.
Xiling LiuClinical Research Center, Shijiazhuang Fifth Hospital, Shijiazhuang, Hebei, China.
Huimin YanClinical Research Center, Shijiazhuang Fifth Hospital, Shijiazhuang, Hebei, China. yanhm2538@163.com.
Fifth Hospital of Shijiazhuang · CN

Funding

Medical Practical Technology Program of Hebei Province GZ2020071Medical Science Research Project of Hebei Province 20230225
6 · The paper itself

Abstract

There is increasing evidence that miRNAs play an important role in the prognosis of HCC. There is currently a lack of acknowledged models that accurately predict patient prognosis. The aim of this study is to create a miRNA-based model to precisely forecast a patient's prognosis and a miRNA-mRNA network to investigate the function of a targeted mRNA. TCGA miRNA dataset and survival data of HCC patients were downloaded for differential analysis. The outcomes of variance analysis were subjected to univariate and multivariate Cox regression analyses and LASSO analysis. We constructed and visualized prognosis-related models and subsequently used violin plots to probe the function of miRNAs in tumor cells. We predicted the target mRNAs added those to the String database, built PPI protein interaction networks, and screened those mRNA using Cytoscape. The hub mRNA was subjected to GO and KEGG analysis to determine its biological role. Six of them were associated with prognosis: hsa-miR-139-3p, hsa-miR-139-5p, hsa-miR-101-3p, hsa-miR-30d-5p, hsa-miR-5003-3p, and hsa-miR-6844. The prognostic model was highly predictive and consistently performs, with the C index exceeding 0.7 after 1, 3, and 5 years. The model estimated significant differences in the Kaplan-Meier plotter and the model could predict patient prognosis independently of clinical indicators. A relatively stable miRNA prognostic model for HCC patients was constructed, and the model was highly accurate in predicting patients with good stability over 5 years. The miRNA-mRNA network was constructed to explore the function of mRNA.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsMicroRNAsGene Regulatory NetworksHumansPrognosisRNA, MessengerMicroRNAsMIRN139 microRNA, humanRNA, MessengerHepatocellular carcinomamiRNAmiRNA–mRNA networkPrognosis

Identifiers

PMID38424172
PMCPMC10904818
OpenAlexW4392282627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.